Milk thistle (Silybum Marianum) as an antidote or a protective agent against natural or chemical toxicities: a review

References

• Abenavoli, L., 2010. Milk thistle in liver diseases: past, present, future. Phytotherapy Research, 24 (10), 1423–1432.
   PubMed Web of Science ®Google Scholar
• Adewale, O., 2015. The potential for plant derivatives against acrylamide neurotoxicity. Phytotherapy Research, 29 (7), 978–985.
   PubMed Web of Science ®Google Scholar
• Ahmad, I., et al., 2013. Biochemical and molecular mechanisms of N-acetyl cysteine and silymarin-mediated protection against maneb-and paraquat-induced hepatotoxicity in rats. Chemico-Biological Interactions, 201 (1), 9–18.
   PubMed Web of Science ®Google Scholar
• Al-Anati, L., et al., 2009. Silibinin protects OTA-mediated TNF-alpha release from perfused rat livers and isolated rat Kupffer cells. Molecular Nutrition & Food Research, 53 (4), 460–466.
   PubMed Web of Science ®Google Scholar
• Alamolhodaei, N.S., Shirani, K., and Karimi, G., 2015. Arsenic cardiotoxicity: an overview. Environmental Toxicology and Pharmacology, 40 (3), 1005–1014.
   PubMed Web of Science ®Google Scholar
• Alcaraz-Contreras, Y., et al., 2016. Silymarin and dimercaptosuccinic acid ameliorate lead-induced nephrotoxicity and genotoxicity in rats. Human & Experimental Toxicology, 35 (4), 398–403.
   PubMed Web of Science ®Google Scholar
• Alvarez-Erviti, L., et al., 2005. Alterations induced in vitro by ochratoxin A in rat lymphoid cells. Human &Amp; Experimental Toxicology, 24 (9), 459–466.
   Google Scholar
• Anon, 1987. Overall evaluations of carcinogenicity: an updating of IARC Monographs volumes 1 to 42. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Supplement, 7, 1–440.
   Google Scholar
• Arshad, S., et al., 1992. Clinico-pathological studies of experimentally induced mycotoxicosis in broiler chickens. Pakistan Veterinary Journal, 12, 183–183.
   Google Scholar
• Asghar, Z., and Masood, Z., 2008. Evaluation of antioxidant properties of silymarin and its potential to inhibit peroxyl radicals in vitro. Pakistan Journal of Pharmaceutical Sciences, 21 (3), 249–254.
   PubMed Web of Science ®Google Scholar
• Aydin, G., et al., 2003. Histopathologic changes in liver and renal tissues induced by Ochratoxin A and melatonin in rats. Human Experimental Toxicology, 22 (7), 383–391.
   PubMed Web of Science ®Google Scholar
• Baluchnejadmojarad, T., Roghani, M., and Mafakheri, M., 2010. Neuroprotective effect of silymarin in 6-hydroxydopamine hemi-parkinsonian rat: involvement of estrogen receptors and oxidative stress. Neuroscience Letters, 480 (3), 206–210.
   PubMed Web of Science ®Google Scholar
• Banaee, M., et al., 2015. Protective effects of silymarin extract on malthion-induced zebra cichlid (Cichlasoma nigrofasciatum) hepatotoxicity. Iranian Journal of Toxicology, 9 (28), 1239–1246.
   Google Scholar
• Begg, E.J., and Barclay, M.L., 1995. Aminoglycosides-50 years on. British Journal of Clinical Pharmacology, 39 (6), 597–603.
   PubMed Web of Science ®Google Scholar
• Bektur, N.E., et al., 2016. Protective effects of silymarin against acetaminophen-induced hepatotoxicity and nephrotoxicity in mice. Toxicology and Industrial Health, 32 (4), 589–600.
   PubMed Web of Science ®Google Scholar
• Blonde-Cynober, F., et al., 1994. Assessment of the carbon tetrachloride-induced cirrhosis model for studies of nitrogen metabolism in chronic liver disease. Annals of Nutrition and Metabolism, 38 (4), 238–248.
   PubMed Web of Science ®Google Scholar
• Blum, R.H., and Carter, S.K., 1974. Adriamycin: a new anticancer drug with significant clinical activity. Annals of Internal Medicine, 80 (2), 249–259.
   PubMed Web of Science ®Google Scholar
• Bondarenko, S., et al., 2004. Persistence of selected organophosphate and carbamate insecticides in waters from a coastal watershed. Environmental Toxicology and Chemistry, 23 (11), 2649–2654.
   PubMed Web of Science ®Google Scholar
• Bongiovanni, G.A., Soria, E.A., and Eynard, A.R., 2007. Effects of the plant flavonoids silymarin and quercetin on arsenite-induced oxidative stress in CHO-K1 cells. Food and Chemical Toxicology, 45 (6), 971–976.
   PubMed Web of Science ®Google Scholar
• Borsari, M., et al., 2001. Silybin, a new iron-chelating agent. Journal of Inorganic Biochemistry, 85 (2-3), 123–129.
   PubMed Web of Science ®Google Scholar
• Campos, R., et al., 1989. Silybin dihemisuccinate protects against glutathione depletion and lipid peroxidation induced by acetaminophen on rat liver. Planta Medica, 55 (5), 417–419.
   PubMed Web of Science ®Google Scholar
• Cebral, E., et al., 1997. Impaired mouse fertilization by low chronic alcohol treatment. Alcohol and Alcoholism (Oxford, Oxfordshire), 32 (5), 563–572.
   PubMed Web of Science ®Google Scholar
• Cecen, E., et al., 2011. Protective effects of silymarin against doxorubicin-induced toxicity. Asian Pacific Journal of Cancer, 12 (10), 2697–2704.
   PubMedGoogle Scholar
• Cersosimo, M.G., and Koller, W.C., 2006. The diagnosis of manganese-induced parkinsonism. Neurotoxicology, 27 (3), 340–346.
   PubMed Web of Science ®Google Scholar
• Chand, N., et al., 2011. Protective effects of milk thistle (Silybum marianum) against aflatoxin B1 in broiler chicks. Asian-Australasian Journal of Animal Sciences, 24 (7), 1011–1018.
   Web of Science ®Google Scholar
• Chen, J.H., et al., 2004. Green tea polyphenols prevent toxin-induced hepatotoxicity in mice by down-regulating inducible nitric oxide-derived prooxidants. The American Journal of Clinical Nutrition, 80 (3), 742–751.
   PubMed Web of Science ®Google Scholar
• Chlopčíková, Š., et al., 2004. Chemoprotective effect of plant phenolics against anthracycline‐induced toxicity on rat cardiomyocytes. Part I. Silymarin and its flavonolignans. Phytotherapy Research, 18 (2), 107–110.
   PubMed Web of Science ®Google Scholar
• Cho, S.I., Lee, J.E., and Do, N.Y., 2014. Protective effect of silymarin against cisplatin-induced ototoxicity. International Journal of Pediatric Otorhinolaryngology, 78 (3), 474–478.
   PubMed Web of Science ®Google Scholar
• Chouhan, S., et al., 2011. Silymarin and quercetin abrogates fluoride induced oxidative stress and toxic effects in rats. Molecular & Cellular Toxicology, 7 (1), 25–32.
   Web of Science ®Google Scholar
• Chrungoo, V. J., Singh, K., and Singh, J., 1997. Silymarin mediated differential modulation of toxicity induced by carbon tetrachloride, paracetamol and D-galactosamine in freshly isolated rat hepatocytes. Indian Journal of Experimental Biology, 35 (6), 611–617.
   PubMedGoogle Scholar
• Chtourou, Y., et al., 2014. Protective role of silymarin against manganese-induced nephrotoxicity and oxidative stress in rat. Environmental Toxicology, 29 (10), 1147–1154.
   PubMed Web of Science ®Google Scholar
• Cicek, E., et al., 2005. Effects of chronic ingestion of sodium fluoride on myocardium in a second generation of rats. Human Experimental Toxicology, 24 (2), 79–87.
   PubMed Web of Science ®Google Scholar
• de Figueiredo, D.R., et al., 2004. Microcystin-producing blooms–a serious global public health issue. Ecotoxicology and Environmental Safety , 59 (2), 151–163.
   PubMed Web of Science ®Google Scholar
• De La Puerta, R., et al., 1996. Effect of silymarin on different acute inflammation models and on leukocyte migration. The Journal of Pharmacy and Pharmacology, 48 (9), 968–970.
   PubMed Web of Science ®Google Scholar
• de Punder, K., and Pruimboom, L., 2015. Stress induces endotoxemia and low-grade inflammation by increasing barrier permeability. Frontiers in Immunology, 6, 223.
   PubMed Web of Science ®Google Scholar
• Dorri, M., Hashemitabar, S., and Hosseinzadeh, H., 2018. Cinnamon (Cinnamomum zeylanicum) as an antidote or a protective agent against natural or chemical toxicities: a review. Drug and Chemical Toxicology, 1, 14.
   Google Scholar
• Dorri, S. A., et al., 2015. Involvement of brain-derived neurotrophic factor (BDNF) on malathion induced depressive-like behavior in subacute exposure and protective effects of crocin. Iranian Journal of Basic Medical Sciences, 18 (10), 958–966.
   PubMed Web of Science ®Google Scholar
• Draz, E. I., et al., 2015. Neurotrophic and antioxidant effects of silymarin comparable to 4-methylcatechol in protection against gentamicin-induced ototoxicity in guinea pigs. Pharmacological Reports, 67 (2), 317–325.
   PubMed Web of Science ®Google Scholar
• Dutta, M., et al., 2014. Silymarin protects against copper-ascorbate induced injury to goat cardiac mitochondria in vitro: involvement of antioxidant mechanism (s). International Journal of Pharmacy and Pharmaceutical Sciences, 6, 422–429.
   Google Scholar
• El-Awady el, S.E., et al., 2011. Cisplatin-induced cardiotoxicity: mechanisms and cardioprotective strategies. European Journal of Pharmacology, 650 (1), 335–341.
   PubMed Web of Science ®Google Scholar
• El-Shitany, N.A., El-Haggar, S., and El-desoky, K., 2008. Silymarin prevents adriamycin-induced cardiotoxicity and nephrotoxicity in rats. Food and Chemical Toxicology , 46 (7), 2422–2428.
   PubMed Web of Science ®Google Scholar
• Escalante, T., et al., 2011. Key events in microvascular damage induced by snake venom hemorrhagic metalloproteinases. Journal of Proteomics, 74 (9), 1781–1794.
   PubMed Web of Science ®Google Scholar
• Eskandari, F., and Momeni, H.R., 2016. Protective effect of silymarin on viability, motility and mitochondrial membrane potential of ram sperm treated with sodium arsenite. International Journal of Reproductive Biomedicine, 14 (6), 397–402.
   PubMed Web of Science ®Google Scholar
• Eskandari, F., and Momeni, H.R., 2016. Silymarin protects plasma membrane and acrosome integrity in sperm treated with sodium arsenite. International Journal of Reproductive Biomedicine, 14 (1), 47–52.
   PubMed Web of Science ®Google Scholar
• Essid, E., Dernawi, Y., and Petzinger, E., 2012. Apoptosis induction by OTA and TNF-alpha in cultured primary rat hepatocytes and prevention by silibinin. Toxins (Basel), 4 (11), 1139–1156.
   PubMed Web of Science ®Google Scholar
• Essid, E., and Petzinger, E., 2011. Silibinin pretreatment protects against ochratoxin A-mediated apoptosis in primary rat hepatocytes. Mycotoxin Research, 27 (3), 167–176.
   PubMedGoogle Scholar
• Falke, H.E., and Zwennis, W.C., 1990. Toxicity of lead acetate to female rabbits after chronic subcutaneous administration. 1. Biochemical and clinical effects. Archives of Toxicology, 64 (7), 522–529.
   PubMed Web of Science ®Google Scholar
• Farghali, H., 2000. Silymarin effects on intracellular calcuim and cytotoxicity: a study in perfused rat hepatocytes after oxidative stress injury. Pharmacological Research, 41 (2), 231–237.
   PubMed Web of Science ®Google Scholar
• Favari, L., and Perez-Alvarez, V., 1997. Comparative effects of colchicine and silymarin on CCl4-chronic liver damage in rats. Archives of Medical Research, 28 (1), 11–17.
   PubMed Web of Science ®Google Scholar
• Fehér, J., Lengyel, G., and Blázovics, A., 1998. Oxidative stress in the liver and biliary tract diseases. Scandinavian Journal of Gastroenterology. Supplement, 228, 38–46.
   PubMedGoogle Scholar
• Fracasso, M.E., et al., 2002. Lead induced DNA strand breaks in lymphocytes of exposed workers: role of reactive oxygen species and protein kinase C. Mutation Research, 515 (1-2), 159–169.
   PubMed Web of Science ®Google Scholar
• Friedman, M., 2003. Chemistry, biochemistry, and safety of acrylamide. A review. Journal of Agricultural and Food Chemistry, 51 (16), 4504–4526.
   PubMed Web of Science ®Google Scholar
• Geed, M., et al., 2014. Silibinin pretreatment attenuates biochemical and behavioral changes induced by intrastriatal MPP + injection in rats. Pharmacology Biochemistry & Behavior, 117, 92–103.
   PubMed Web of Science ®Google Scholar
• Geyikoglu, F., et al., 2013. The genotoxic, hepatotoxic, nephrotoxic, haematotoxic and histopathological effects in rats after aluminium chronic intoxication. Toxicology and Industrial Health, 29 (9), 780–791.
   PubMed Web of Science ®Google Scholar
• Gharagozloo, M., Khoshdel, Z., and Amirghofran, Z., 2008. The effect of an iron (III) chelator, silybin, on the proliferation and cell cycle of Jurkat cells: a comparison with desferrioxamine. European Journal of Pharmacology, 589 (1-3), 1–7.
   PubMed Web of Science ®Google Scholar
• Guo, T.L., et al., 1998. Mercuric chloride induces apoptosis in human T lymphocytes: evidence of mitochondrial dysfunction. Toxicology and Applied Pharmacology, 153 (2), 250–257.
   PubMed Web of Science ®Google Scholar
• Hamid, A.S., et al., 2013. Aflatoxin B1-induced hepatocellular carcinoma in developing countries: Geographical distribution, mechanism of action and prevention. Oncology Letters, 5 (4), 1087–1092.
   PubMed Web of Science ®Google Scholar
• Hao, S., et al., 2002. Protective effect of extra metallothioneins from rabbit liver induced by zinc on toxicity of lead in rat primary hepatocyte culture. Wei Sheng Yan Jiu, 31 (4), 229–231.
   PubMedGoogle Scholar
• Hillam, R.P., and Ozkan, A.N., 1986. Comparison of local and systemic immunity after intratracheal, intraperitoneal, and intravenous immunization of mice exposed to either aerosolized or ingested lead. Environmental Research, 39 (2), 265–277.
   PubMed Web of Science ®Google Scholar
• Hosseini, S.M., et al., 2017. Protective effect of thymoquinone, the active constituent of Nigella sativa fixed oil, against ethanol toxicity in rats. Iranian Journal of Basic Medical Sciences, 20 (8), 927–939.
   PubMed Web of Science ®Google Scholar
• Hu, Q., et al., 2015. Rapid methods for detecting acrylamide in thermally processed foods: a review. Food Control, 56, 135–146.
   Web of Science ®Google Scholar
• Jain, A., et al., 2011. Therapeutic efficacy of silymarin and naringenin in reducing arsenic-induced hepatic damage in young rats. Ecotoxicology and Environmental Safety, 74 (4), 607–614.
   PubMed Web of Science ®Google Scholar
• Jalali, M. R., et al., 2010. Effects of silymarin and polyvalent antivenom (Pva) on renal biochemical indicators after envenomation with Hemiscorpius lepturus scorpion venom in rats. Biochemical and Cellular Archives, 10 (1), 123–128.
   Google Scholar
• Jangra, A., et al., 2015. Hesperidin and silibinin ameliorate aluminum-induced neurotoxicity: modulation of antioxidants and inflammatory cytokines level in mice hippocampus. Biological Trace Element Research, 168 (2), 462–471.
   PubMed Web of Science ®Google Scholar
• Jayaraj, R., et al., 2007. Hepatoprotective efficacy of certain flavonoids against microcystin induced toxicity in mice. Environmental Toxicology, 22 (5), 472–479.
   PubMed Web of Science ®Google Scholar
• Jia, J.D., et al., 2001. Antifibrotic effect of silymarin in rat secondary biliary fibrosis is mediated by downregulation of procollagen alpha1(I) and TIMP-1. Journal of Hepatology, 35 (3), 392–398.
   PubMed Web of Science ®Google Scholar
• Kang, J.S., et al., 2004. Protection against lipopolysaccharide-induced sepsis and inhibition of interleukin-1β and prostaglandin E2 synthesis by silymarin. Biochem Pharmacol, 67 (1), 175–181.
   PubMed Web of Science ®Google Scholar
• Karimi, G., Ramezani, M., and Tahoonian, Z., 2005. Cisplatin nephrotoxicity and protection by milk thistle extract in rats. Evidence-Based Complementary and Alternative Medicine, 2 (3), 383–386.
   PubMed Web of Science ®Google Scholar
• Kemparaju, K., and Girish, K.S., 2006. Snake venom hyaluronidase: a therapeutic target. Cell Biochemistry and Function, 24 (1), 7–12.
   PubMed Web of Science ®Google Scholar
• Khandelwal, P.J., Herman, A.M., and Moussa, C.E.-H., 2011. Inflammation in the early stages of neurodegenerative pathology. Journal of Neuroimmunology, 238 (1-2), 1–11.
   PubMed Web of Science ®Google Scholar
• Khatoon, A., et al., 2013. Amelioration of ochratoxin A-induced immunotoxic effects by silymarin and Vitamin E in White Leghorn cockerels. Journal of Immunotoxicology, 10 (1), 25–31.
   PubMed Web of Science ®Google Scholar
• Kim, J., and Sharma, R.P., 2006. Cadmium-induced apoptosis in murine macrophages is antagonized by antioxidants and caspase inhibitors. Journal of Toxicology and Environmental Health, Part A, 69 (12), 1181–1201.
   PubMed Web of Science ®Google Scholar
• Kim, S.H., and Sharma, R.P., 2004. Mercury-induced apoptosis and necrosis in murine macrophages: role of calcium-induced reactive oxygen species and p38 mitogen-activated protein kinase signaling. Toxicology and Applied Pharmacology, 196 (1), 47–57.
   PubMed Web of Science ®Google Scholar
• Kovarik, J.M., and Burtin, P., 2003. Immunosuppressants in advanced clinical development for organ transplantation and selected autoimmune diseases. Expert Opinion on Emerging Drugs, 8 (1), 47–62.
   PubMedGoogle Scholar
• Kronbach, T., Fischer, V., and Meyer, U.A., 1988. Cyclosporine metabolism in human liver: identification of a cytochrome P-450III gene family as the major cyclosporine-metabolizing enzyme explains interactions of cyclosporine with other drugs. Clinical Pharmacology and Therapeutics, 43 (6), 630–635.
   PubMed Web of Science ®Google Scholar
• Kumar, V., and Gill, K.D., 2014. Oxidative stress and mitochondrial dysfunction in aluminium neurotoxicity and its amelioration: a review. Neurotoxicology, 41, 154–166.
   PubMed Web of Science ®Google Scholar
• Lee, T.Y., et al., 2003. Protective mechanism of salvia miltiorrhiza on carbon tetrachloride-induced acute hepatotoxicity in rats. Journal of Pharmacological Sciences, 91 (3), 202–210.
   PubMed Web of Science ®Google Scholar
• Lee, Y., et al., 2015. Silibinin suppresses astroglial activation in a mouse model of acute Parkinson's disease by modulating the ERK and JNK signaling pathways. Brain Research, 1627, 233–242.
   PubMed Web of Science ®Google Scholar
• Lee, Y., et al., 2015. Silibinin prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease via mitochondrial stabilization. Journal of Neuroscience Research, 93 (5), 755–765.
   PubMed Web of Science ®Google Scholar
• Letteron, P., et al., 1990. Mechanism for the protective effects of silymarin against carbon tetrachloride-induced lipid peroxidation and hepatotoxicity in mice. Evidence that silymarin acts both as an inhibitor of metabolic activation and as a chain-breaking antioxidant. Biochemical Pharmacology, 39 (12), 2027–2034.
   PubMed Web of Science ®Google Scholar
• Li, L., et al., 2017. Silymarin protects against acrylamide-induced neurotoxicity via Nrf2 signalling in PC12 cells. Food and Chemical Toxicology, 102, 93–101.
   PubMed Web of Science ®Google Scholar
• Lu, P., et al., 2009. Silibinin attenuates amyloid β25–35 peptide-induced memory impairments: implication of inducible nitric-oxide synthase and tumor necrosis factor-α in mice. Journal of Pharmacology and Experimental Therapeutics, 331 (1), 319–326.
   PubMed Web of Science ®Google Scholar
• Lu, P., et al., 2009. Silibinin prevents amyloid β peptide‐induced memory impairment and oxidative stress in mice. British Journal of Pharmacology, 157 (7), 1270–1277.
   PubMed Web of Science ®Google Scholar
• Lucena, M.I., et al., 2002. Effects of silymarin MZ-80 on oxidative stress in patients with alcoholic cirrhosis. Results of a randomized, double-blind, placebo-controlled. International Journal of Clinical Pharmacology and Therapeutics, 40 (1), 2–8.
   PubMed Web of Science ®Google Scholar
• Luper, S., 1998. A review of plants used in the treatment of liver disease: part 1. Alternative Medicine Review , 3 (6), 410–421.
   PubMedGoogle Scholar
• Manna, S. K., et al., 1999. Silymarin suppresses TNF-induced activation of NF-kappa B, c-Jun N-terminal kinase, and apoptosis. Journal of Immunology, 163 (12), 6800–6809.
   PubMed Web of Science ®Google Scholar
• Mansour, H.H., Hafez, H.F., and Fahmy, N.M., 2006. Silymarin modulates cisplatin-induced oxidative stress and hepatotoxicity in rats. Journal of Biochemistry and Molecular Biology, 39 (6), 656–661.
   PubMedGoogle Scholar
• Marchlewicz, M., et al., 1993. Effect of long-term exposure to lead on testis and epididymis in rats. Folia Histochemica Et Cytobiologica, 31 (2), 55–62.
   PubMed Web of Science ®Google Scholar
• Mehdizadeh, R., et al., 2013. Cardioprotective effect of saffron extract and safranal in isoproterenol-induced myocardial infarction in wistar rats. Iranian Journal of Basic Medical Sciences, 16 (1), 56–63.
   PubMed Web of Science ®Google Scholar
• Mehri, S., et al., 2016. Evaluation of the neuroprotective effect of silymarin on acrylamide-induced neurotoxicity. Jundishapur Journal of Natural Pharmaceutical Products, 11 (4), e37644.
   Web of Science ®Google Scholar
• Meili, S., et al., 2016. Inhibitory effect of silymarin preconditioning on acrylamide-induced apoptosis in hepatocyte and its mechanism. Journal of Chinese Institute of Food Science and Technology, 4, 18–24.
   Google Scholar
• Mereish, K.A., and Solow, R., 1990. Effect of antihepatotoxic agents against microcystin-LR toxicity in cultured rat hepatocytes. Pharmaceutical Research, 7 (3), 256–261.
   PubMed Web of Science ®Google Scholar
• Merxmuller, H., et al., 1977. The biology and chemistry of compositae. In V.H. Heyood, J.B. Harborne and B.L. Turner, eds. London: Academic Press, 586.
   Google Scholar
• Mira, L., Silva, M., and Manso, C.F., 1994. Scavenging of reactive oxygen species by silibinin dihemisuccinate. Biochemical Pharmacology, 48 (4), 753–759.
   PubMed Web of Science ®Google Scholar
• Mohammadzadeh, L., et al., 2017a. Neuroprotective potential of crocin against malathion-induced motor deficit and neurochemical alterations in rats. Environmental Science and Pollution Research, 25 (5), 4904–4914.
   PubMed Web of Science ®Google Scholar
• Mohammadzadeh, N., Mehri, S., and Hosseinzadeh, H., 2017. Berberis vulgaris and its constituent berberine as antidotes and protective agents against natural or chemical toxicities. Iranian Journal of Basic Medical Sciences, 20 (5), 538–551.
   PubMed Web of Science ®Google Scholar
• Momeni, A., et al., 2015. Effect of silymarin in the prevention of Cisplatin nephrotoxicity, a clinical trial study. Journal of Clinical and Diagnostic Research, 9 (4), OC11–Oc13.
   PubMed Web of Science ®Google Scholar
• Moon, K., Guallar, E., and Navas-Acien, A., 2012. Arsenic exposure and cardiovascular disease: an updated systematic review. Current Atherosclerosis Reports, 14 (6), 542–555.
   PubMed Web of Science ®Google Scholar
• Moulisova, V., et al., 2006. Silybin reduces lipid peroxidation of rat hepatocyte membrane caused by cyclosporin A. Biochemistry (Mosc), 71 (10), 1110–1114.
   PubMed Web of Science ®Google Scholar
• Murata, N., et al., 2010. Silymarin attenuated the amyloid beta plaque burden and improved behavioral abnormalities in an Alzheimer's disease mouse model. Bioscience, Biotechnology, and Biochemistry, 74 (11), 2299–2306.
   PubMed Web of Science ®Google Scholar
• Murphy, C.J., and Oudit, G.Y., 2010. Iron-overload cardiomyopathy: pathophysiology, diagnosis, and treatment. Journal of Cardiac Failure, 16 (11), 888–900.
   PubMed Web of Science ®Google Scholar
• Muthumani, M., and Prabu, S.M., 2014. Silibinin potentially attenuates arsenic-induced oxidative stress mediated cardiotoxicity and dyslipidemia in rats. Cardiovascular Toxicology, 14 (1), 83–97.
   PubMed Web of Science ®Google Scholar
• Muzes, G., et al., 1991. Effect of the bioflavonoid silymarin on the in vitro activity and expression of superoxide dismutase (SOD) enzyme. Acta Physiologica Hungarica, 78 (1), 3–9.
   PubMedGoogle Scholar
• Nabavi, S., et al., 2011. Protective effects of curcumin against fluoride-induced oxidative stress in the rat brain. Neurophysiology, 43 (4), 287–291.
   Web of Science ®Google Scholar
• Nabavi, S.M., et al., 2012. Neuroprotective effects of silymarin on sodium fluoride-induced oxidative stress. Journal of Fluorine Chemistry, 142, 79–82.
   Web of Science ®Google Scholar
• Nabavi, S.M., et al., 2012. Cytoprotective effect of silymarin against sodium fluoride-induced oxidative stress in rat erythrocytes. Fluoride, 45 (1), 27–34.
   Web of Science ®Google Scholar
• Najafzadeh, H., et al., 2010. Comparison of the prophylactic effect of silymarin and deferoxamine on iron overload-induced hepatotoxicity in rat. Journal of Medical Toxicology, 6 (1), 22–26.
   PubMedGoogle Scholar
• Nanjaraj Urs, A.N., et al., 2015. Progressive hemorrhage and myotoxicity induced by echis carinatus venom in murine model: neutralization by inhibitor cocktail of N,N,N',N'-Tetrakis (2-Pyridylmethyl) ethane-1,2-diamine and silymarin. PLoS One, 10 (8), e0135843.
   PubMed Web of Science ®Google Scholar
• Navidi-Shishaone, M., et al., 2014. Co-Administration of silymarin and deferoxamine against kidney, liver and heart iron deposition in male iron overload rat model. International Journal of Preventive Medicine, 5 (1), 110–116.
   PubMedGoogle Scholar
• Nencini, C., Giorgi, G., and Micheli, L., 2007. Protective effect of silymarin on oxidative stress in rat brain. Phytomedicine: International Journal of Phytotherapy and Phytopharmacology, 14 (2-3), 129–135.
   PubMed Web of Science ®Google Scholar
• Ninsontia, C., et al., 2011. Silymarin selectively protects human renal cells from cisplatin-induced cell death. Pharmaceutical Biology, 49 (10), 1082–1090.
   PubMed Web of Science ®Google Scholar
• O'Brien, E., and Dietrich, D.R., 2005. Ochratoxin A: the continuing enigma. Critical Reviews in Toxicology, 35 (1), 33–60.
   PubMed Web of Science ®Google Scholar
• Olaleye, M., Adegboye, O., and Akindahunsi, A., 2006. Alchornea cordifolia extract protects wistar albino rats against acetaminophen-induced liver damage. African Journal of Biotechnology, 5 (24), 2439–2445.
   Google Scholar
• Ottai, M., and Abdel-Moniem, A., 2006. Genetic parameter variations among milk thistle, Silybum marianum varieties and varietal sensitivity to infestation with seed-head weevil, Larinus latus Herbst. International Journal of Agriculture and Biology, 6, 862–866.
   Google Scholar
• Par, A., et al., 2000. Oxidative stress and antioxidant defense in alcoholic liver disease and chronic hepatitis C. Orvosi Hetilap, 141 (30), 1655–1659.
   PubMedGoogle Scholar
• Patel, N., et al., 2010. Silymarin modulates doxorubicin-induced oxidative stress, Bcl-xL and p53 expression while preventing apoptotic and necrotic cell death in the liver. Toxicology and Applied Pharmacology, 245 (2), 143–152.
   PubMed Web of Science ®Google Scholar
• Pereira, N.A., et al., 1994. Pharmacological screening of plants recommended by folk medicine as snake venom antidotes; IV. Protection against Jararaca venom by isolated constituents1. Planta Medica, 60 (02), 99–100.
   Web of Science ®Google Scholar
• Pérez-H, J., et al., 2014. Neuroprotective effect of silymarin in a MPTP mouse model of Parkinson's disease. Toxicology, 319, 38–43.
   PubMed Web of Science ®Google Scholar
• Phillipson, J.D., and Anderson, L.A., 1989. Ethnopharmacology and western medicine. Journal of Ethnopharmacology, 25 (1), 61–72.
   PubMed Web of Science ®Google Scholar
• Podder, B., et al., 2012. Antioxidant effect of silymarin on paraquat-induced human lung adenocarcinoma A549 cell line. Food and Chemical Toxicology , 50 (9), 3206–3214.
   PubMed Web of Science ®Google Scholar
• Pook, S.H., Toh, C.K., and Mahendran, R., 2006. Combination of thiol antioxidant Silibinin with Brostallicin is associated with increase in the anti-apoptotic protein Bcl-2 and decrease in caspase 3 activity. Cancer Letters, 238 (1), 146–152.
   PubMed Web of Science ®Google Scholar
• Pourbakhsh, H., et al., 2014. Effect of Nigella sativa fixed oil on ethanol toxicity in rats. Iranian Journal of Basic Medical Sciences, 17 (12), 1020–1031.
   PubMed Web of Science ®Google Scholar
• Prabu, S.M., and Muthumani, M., 2012. Silibinin ameliorates arsenic induced nephrotoxicity by abrogation of oxidative stress, inflammation and apoptosis in rats. Molecular Biology Reports, 39 (12), 11201–11216.
   PubMed Web of Science ®Google Scholar
• Rahim, M., et al., 1999. Immuno-modulatory and growth inhibitory effects of mycotoxins (Aflatoxin B1) in broiler chickens and the reversal influence of hydrated sodium calcium aluminosilicate. Pakistan Journal of Biological Sciences (Pakistan), 2 (3), 1027–1029.
   Google Scholar
• Rameshrad, M., Razavi, B.M., and Hosseinzadeh, H., 2017. Protective effects of green tea and its main constituents against natural and chemical toxins: A comprehensive review. Food and Chemical Toxicology , 100, 115–137.
   PubMed Web of Science ®Google Scholar
• Rao, P.V., Jayaraj, R., and Bhaskar, A.S., 2004. Protective efficacy and the recovery profile of certain chemoprotectants against lethal poisoning by microcystin-LR in mice. Toxicon, 44 (7), 723–730.
   PubMed Web of Science ®Google Scholar
• Raskovic, A., et al., 2011. The protective effects of silymarin against doxorubicin-induced cardiotoxicity and hepatotoxicity in rats. Molecules, 16 (10), 8601–8613.
   PubMed Web of Science ®Google Scholar
• Rastogi, R., Srivastava, A.K., and Rastogi, A.K., 2001. Long term effect of aflatoxin B(1) on lipid peroxidation in rat liver and kidney: effect of picroliv and silymarin. Phytotherapy Research, 15 (4), 307–310.
   PubMed Web of Science ®Google Scholar
• Razavi, B.M., and Hosseinzadeh, H., 2015. Saffron as an antidote or a protective agent against natural or chemical toxicities. DARU Journal of Pharmaceutical Sciences, 23 (1), 31.
   Google Scholar
• Rechnagel, R.O., and Glende, E.A., Jr. 1973. Carbon tetrachloride hepatotoxicity: an example of lethal cleavage. CRC Critical Reviews in Toxicology, 2 (3), 263–297.
   PubMedGoogle Scholar
• Saad, S.Y., Najjar, T.A., and Alashari, M., 2004. Role of non‐selective adenosine receptor blockade and phosphodiesterase inhibition in cisplatin‐induced nephrogonadal toxicity in rats. Clinical and Experimental Pharmacology and Physiology, 31 (12), 862–867.
   PubMed Web of Science ®Google Scholar
• Saller, R., Meier, R., and Brignoli, R., 2001. The use of silymarin in the treatment of liver diseases. Drugs, 61 (14), 2035–2063.
   PubMed Web of Science ®Google Scholar
• Santamaria, A., 2008. Manganese exposure, essentiality & toxicity. The Indian Journal of Medical Research, 128 (4), 484.
   PubMed Web of Science ®Google Scholar
• Sauvant, C., Holzinger, H., and Gekle, M., 2005. The nephrotoxin ochratoxin A induces key parameters of chronic interstitial nephropathy in renal proximal tubular cells. Cellular Physiology and Biochemistry, 15 (1-4), 125–134.
   PubMed Web of Science ®Google Scholar
• Schreiber, S.L., and Crabtree, G.R., 1992. The mechanism of action of cyclosporin A and FK506. Immunology Today, 13 (4), 136–142.
   PubMedGoogle Scholar
• Shafiq-ur-Rehman, S., 1991. Effects of lead on the behavioral complex stereotypes and regional brain dopamine levels in rats. Archives of Environmental Contamination and Toxicology, 20 (4), 527–530.
   PubMed Web of Science ®Google Scholar
• Shahbazi, F., et al., 2015. Effect of silymarin administration on cisplatin nephrotoxicity: report from a pilot, randomized, double-blinded, placebo-controlled clinical trial. Phytotherapy Research, 29 (7), 1046–1053.
   PubMed Web of Science ®Google Scholar
• Shalan, M.G., et al., 2005. Amelioration of lead toxicity on rat liver with vitamin C and silymarin supplements. Toxicology, 206 (1), 1–15.
   PubMed Web of Science ®Google Scholar
• Shin, J.H., et al., 2013. Protective effect of silymarin against ethanol-induced gastritis in rats: role of sulfhydryls, nitric oxide and gastric sensory afferents. Food and Chemical Toxicology, 55, 353–357.
   PubMed Web of Science ®Google Scholar
• Shukla, R., et al., 1991. Lead exposure and growth in the early preschool child: a follow-up report from the Cincinnati Lead Study. Pediatrics, 88 (5), 886–892.
   PubMed Web of Science ®Google Scholar
• Silbergeld, E.K., Sacci, J.B., Jr., and Azad, A.F., 2000. Mercury exposure and murine response to Plasmodium yoelii infection and immunization. Immunopharmacology and Immunotoxicology, 22 (4), 685–695.
   PubMed Web of Science ®Google Scholar
• Singhal, N.K., et al., 2011. Melatonin or silymarin reduces maneb- and paraquat-induced Parkinson's disease phenotype in the mouse . Journal of Pineal Research, 50 (2), 97–109.
   PubMed Web of Science ®Google Scholar
• Skottova, N., et al., 2003. Effects of polyphenolic fraction of silymarin on lipoprotein profile in rats fed cholesterol-rich diets. Pharmacological Research, 47 (1), 17–26.
   PubMed Web of Science ®Google Scholar
• Smeyne, R.J., and Jackson-Lewis, V., 2005. The MPTP model of Parkinson's disease. Brain Research. Molecular Brain Research, 134 (1), 57–66.
   PubMedGoogle Scholar
• Soares, A.M., et al., 2005. Medicinal plants with inhibitory properties against snake venoms. Current Medicinal Chemistry, 12 (22), 2625–2641.
   PubMed Web of Science ®Google Scholar
• Song, X., et al., 2016. Protective effect of silibinin on learning and memory impairment in LPS-treated rats via ROS-BDNF-TrkB Pathway. Neurochemical Research, 41 (7), 1662–1672.
   PubMed Web of Science ®Google Scholar
• Song, Z., et al., 2006. Silymarin protects against acute ethanol‐induced hepatotoxicity in mice. Alcoholism: Clinical and Experimental Research, 30 (3), 407–413.
   PubMed Web of Science ®Google Scholar
• Soria, E.A., Eynard, A.R., and Bongiovanni, G.A., 2010. Cytoprotective effects of silymarin on epithelial cells against arsenic-induced apoptosis in contrast with quercetin cytotoxicity. Life Science, 87 (9-10), 309–315.
   PubMed Web of Science ®Google Scholar
• Srinivasan, R., and Ramprasath, C., 2012a. Beneficial role of silibinin in monitoring the cadmium induced hepatotoxicity in Albino Wistar rats. Recent Research in Science and Technology, 4 (1), 46–52.
   Google Scholar
• Srinivasan, R., and Ramprasath, C., 2012b. Protective role of silibinin in cadmium induced changes of acetylcholinesterase, ATPases and oxidative stress in brain of albino wistar rats. Journal of Ecobiotechnology, 3 (11), 34–39.
   Google Scholar
• Srivastava, G., et al., 2012. Resveratrol potentiates cytochrome P450 2 d22-mediated neuroprotection in maneb- and paraquat-induced parkinsonism in the mouse. Free Radical Biology and Medicine, 52 (8), 1294–1306.
   PubMed Web of Science ®Google Scholar
• Sroczynski, J., et al., 1987. Biochemical studies in the evaluation of the health status of workers chronically exposed to lead. Med Pr, 38 (6), 429–436.
   PubMedGoogle Scholar
• Steinberg, D., 1997. Low density lipoprotein oxidation and its pathobiological significance. The Journal of Biological Chemistry, 272 (34), 20963–20966.
   PubMed Web of Science ®Google Scholar
• Stoev, S.D., et al., 2000. Influence of ochratoxin A and an extract of artichoke on the vaccinal immunity and health in broiler chicks. Experimental and Toxicologic Pathology: Official Journal of the Gesellschaft Fur Toxikologische Pathologie, 52 (1), 43–55.
   PubMed Web of Science ®Google Scholar
• Stolf, A.M., Cardoso, C.C., and Acco, A., 2017. Effects of silymarin on diabetes mellitus complications: a review. Phytotherapy Research : Ptr, 31 (3), 366–374.
   PubMed Web of Science ®Google Scholar
• Suntres, Z.E., 2002. Role of antioxidants in paraquat toxicity. Toxicology, 180 (1), 65–77.
   PubMed Web of Science ®Google Scholar
• Tacar, O., Sriamornsak, P., and Dass, C.R., 2013. Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems. Journal of Pharmacy and Pharmacology, 65 (2), 157–170.
   PubMed Web of Science ®Google Scholar
• Tedesco, D., et al., 2004. Efficacy of silymarin-phospholipid complex in reducing the toxicity of aflatoxin B1 in broiler chicks. Poultry Science, 83 (11), 1839–1843.
   PubMed Web of Science ®Google Scholar
• Teixeira, C.F., et al., 2003. Inflammatory effects of snake venom myotoxic phospholipases A2. Toxicon, 42 (8), 947–962.
   PubMed Web of Science ®Google Scholar
• Thomas, M.J., et al., 1997. A comparison of the kinetics of low-density lipoprotein oxidation initiated by copper or by azobis (2-amidinopropane). Free Radical Biology and Medicine, 23 (6), 927–935.
   PubMed Web of Science ®Google Scholar
• Tomljenovic, L., 2011. Aluminum and Alzheimer's disease: after a century of controversy, is there a plausible link?. Journal of Alzheimer's Disease, 23 (4), 567–598.
   PubMed Web of Science ®Google Scholar
• Tsai, J.H., et al., 2008. Effects of silymarin on the resolution of liver fibrosis induced by carbon tetrachloride in rats. Journal of Viral Hepatitis, 15 (7), 508–514.
   PubMed Web of Science ®Google Scholar
• Vahdati Hasani, F., et al., 2016. Silybum marianum extract reduced acrylamide-induced neurotoxicity in both in vitro and in vivo assessments. Medical Journal of Mashhad University of Medical Sciences, 59, 60.
   Google Scholar
• Vakulenko, S.B., and Mobashery, S., 2003. Versatility of aminoglycosides and prospects for their future. Clinical Microbiology Reviews, 16 (3), 430–450.
   PubMed Web of Science ®Google Scholar
• Valenzuela, A., et al., 1989. Selectivity of silymarin on the increase of the glutathione content in different tissues of the rat. Planta Medica, 55 (5), 420–422.
   PubMed Web of Science ®Google Scholar
• Valenzuela, A., Guerra, R., and Videla, L.A., 1986. Antioxidant properties of the flavonoids silybin and (+)-cyanidanol-3: comparison with butylated hydroxyanisole and butylated hydroxytoluene. Planta Medica, 52 (06), 438–440.
   Web of Science ®Google Scholar
• Varzi, H.N., et al., 2007. Effect of silymarin and vitamin E on gentamicin-induced nephrotoxicity in dogs. Journal of Veterinary Pharmacology and Therapeutics, 30 (5), 477–481.
   PubMed Web of Science ®Google Scholar
• Vázquez-Claverie, M., et al., 2009. Acute and chronic 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine administrations elicit similar microglial activation in the substantia nigra of monkeys. Journal of Neuropathology & Experimental Neurology, 68 (9), 977–984.
   PubMed Web of Science ®Google Scholar
• von Schönfeld, J., Weisbrod, B., and Müller, M.K., 1997. Silibinin, a plant extract with antioxidant and membrane stabilizing properties, protects exocrine pancreas from cyclosporin A toxicity. Cellular and Molecular Life Sciences, 53 (12), 917–920.
   PubMed Web of Science ®Google Scholar
• Vyskocil, A., et al., 1991. The urinary excretion of specific proteins in workers exposed to lead. Archives of Toxicology. Supplement. = Archiv Fur Toxikologie. Supplement, 14, 218–221.
   PubMedGoogle Scholar
• Wahsha, M., and Al-Jassabi, S., 2009. The role of Silymarin in the protection of mice liver damage against Microcystin-LR toxicity. Jordan Journal of Biological Sciences, 2 (2), 63–68.
   Google Scholar
• Wang, C.-H., et al., 2007. A review of the epidemiologic literature on the role of environmental arsenic exposure and cardiovascular diseases. Toxicology and Applied Pharmacology, 222 (3), 315–326.
   PubMed Web of Science ®Google Scholar
• Wang, M.J., et al., 2002. Silymarin protects dopaminergic neurons against lipopolysaccharide-induced neurotoxicity by inhibiting microglia activation. European Journal of Neuroscience, 16 (11), 2103–2112.
   PubMed Web of Science ®Google Scholar
• Wang, Y., et al., 2011. Iron-induced cardiac damage: role of apoptosis and deferasirox intervention. The Journal of Pharmacology and Experimental Therapeutics, 336 (1), 56–63.
   PubMed Web of Science ®Google Scholar
• Winneke, G., Collet, W., and Lilienthal, H., 1988. The effects of lead in laboratory animals and environmentally-exposed children. Toxicology, 49 (2-3), 291–298.
   PubMed Web of Science ®Google Scholar
• Xu, C., et al., 2007. Protective effects of green tea polyphenols against subacute hepatotoxicity induced by microcystin-LR in mice. Environmental Toxicology and Pharmacology, 24 (2), 140–148.
   PubMed Web of Science ®Google Scholar
• Yaghmaei, P., et al., 2014. Silymarin effect on amyloid-β plaque accumulation and gene expression of APP in an Alzheimer's disease rat model. Daru: Journal of Faculty of Pharmacy, Tehran University of Medical Sciences, 22 (1), 24.
   PubMed Web of Science ®Google Scholar
• Yamauchi, H., et al., 2004. Evaluation of DNA damage in patients with arsenic poisoning: urinary 8-hydroxydeoxyguanine. Toxicology and Applied Pharmacology, 198 (3), 291–296.
   PubMed Web of Science ®Google Scholar
• Yokel, R.A., and McNamara, P.J., 2001. Aluminium toxicokinetics: an updated minireview. Pharmacol. Toxicol, 88 (4), 159–167.
   PubMedGoogle Scholar
• Zhou, B., et al., 2006. Silibinin protects against isoproterenol-induced rat cardiac myocyte injury through mitochondrial pathway after up-regulation of SIRT1. Journal of Pharmacological Sciences, 102 (4), 387–395.
   PubMed Web of Science ®Google Scholar
• Zicca, A., et al., 2002. Reduction of cisplatin hepatotoxicity by procainamide hydrochloride in rats. European Journal of Pharmacology, 442 (3), 265–272.
   PubMed Web of Science ®Google Scholar